Vomitoxin-induced cyclooxygenase-2 gene expression in macrophages mediated by activation of ERK and p38 but not JNK mitogen-activated protein kinases
Abstract
Vomitoxin (VT) and other trichothecene mycotoxins mediate a broad range of immunotoxic effects via the induction of inflammation-associated genes in leukocytes. The purpose of this study was to test the hypothesis that VT induces cyclooxygenase-2 (COX-2) gene expression in macrophages and that this is regulated at the level of mitogen-activated protein kinases (MAPKs). Exposure of the murine macrophage cell line RAW 264.7 to 50-250 ng/ml VT for 24 h markedly enhanced the production of prostaglandin E(2) (PGE(2)), a major COX-2 metabolite. PGE(2) elevation was preceded by increases in COX-2 mRNA (2 h) and COX-2 protein (15 h) in VT-treated cells. VT induced rapid (15 min) and persistent (up to 240 min) phosphorylation of extracellular, signal regulated protein kinases 1 and 2 (ERK1/2) and p38 MAPK as well as a rapid (15 min) but transient (up to 60 min) phosphorylation of c-Jun N-terminal kinases 1 and 2 (JNK1/2). The ERK inhibitor PD98059 and p38 inhibitor SB203580 suppressed VT-induced PGE(2) and COX-2 protein expression, whereas impairment of JNK function by transient transfection with a dominant negative (dn) JNK vector had no effect on COX-2 protein expression. Relatedly, in cells transfected with a COX-2 promoter-luciferase construct, PD98059- and SB203580-, but not dnJNK-treatment, suppressed VT-induced luciferase transcription. VT also increased COX-2 mRNA stability, and this was inhibited by PD98059 but not by SB203580. Taken together, these results indicate that VT-induced PGE(2) production and COX-2 expression by elevating transcriptional activity and mRNA stability. Enhanced transcriptional activity was modulated by ERK and p38 signaling pathways, whereas mRNA stability was promoted exclusively by VT-activated p38 phosphorylation. These data provide insight into possible general mechanisms by which VT and other trichlothecenes upregulate proinflammatory genes and impart immunotoxicity.
Key Biomarkers
Cited By (7)
- Deoxynivalenol-Induced Proinflammatory Gene Expression: Mechanisms and Pathological SequelaeToxins · 2010
- Fungal Toxins and Host Immune ResponsesFrontiers in Microbiology · 2021
- Transcriptional and posttranscriptional roles for p38 mitogen-activated protein kinase in upregulation of TNF-α expression by deoxynivalenol (vomitoxin)Toxicology and Applied Pharmacology · 2003
- Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradoxToxicology Letters · 2004
- Relationship of Trichothecene Structure to Cox-2 Induction in the Macrophage: Selective Action of Type B (8-Keto) TrichothecenesJournal of Toxicology and Environmental Health · 2003
- Global protein phosphorylation dynamics during deoxynivalenol-induced ribotoxic stress response in the macrophageToxicology and Applied Pharmacology · 2013
- The Fusarium toxin deoxynivalenol disrupts phenotype and function of monocyte-derived dendritic cells in vivo and in vitro
Related Papers
- Hazard characterization of Alternaria toxins to identify data gaps and improve risk assessment for human healthArchives of Toxicology · 2023 · 2 shared tags
- Timing of gene expression alters susceptibility to aflatoxicosis: a heterogeneous spectrum of disease in response to a single universal agentEgyptian Journal of Medical Human Genetics · 2025 · 2 shared tags
- Effect of Ochratoxin A (OTA) on the Immune System: A Systematic ReviewToxins · 2025 · 2 shared tags
- Mold, Mycotoxins and a Dysregulated Immune System: A Combination of Concern?International Journal of Molecular Sciences · 2021 · 2 shared tags
- HLA gene variations and mycotoxin toxicity: Four case reportsMycotoxin Research · 2024 · 2 shared tags
- Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune ProcessesClinical Therapeutics · 2018 · 2 shared tags